All
Moisturizing mechanism, MVEs; ph-balanced cleansers
October 21st 2005This seems like a very simple question, but in actuality is quite complex. Just walk up and down the drug store aisle and look at all of the moisturizers. Each manufacturer claims to have found the perfect method for skin moisturization, but in actuality, all companies are still searching for the complete answer. How do I know this? Simply because each year new moisturizers enter the market and older versions are withdrawn.
Choosing a partner wisely: Derms look at more than just resume
October 21st 2005A common analogy in the medical business today is that a group practice is like a marriage. Medical partners often spend more time together than many married couples, and may have as much financial intertwining as most spouses.
Katrina washes away lives-but not hope
October 21st 2005At press time, a portion of New Orleans had suffered more flooding from a second storm, Hurricane Rita. Federal officials said it would take two to three weeks to pump out the additional floodwaters. The Army Corps of Engineers estimates the city's system of levees won't be completely repaired until next June, according to news reports.
Dermatoscopy helps dermatologist recognize melanoma earlier
October 21st 2005Chicago —Although the increase in melanoma incidence shows no sign of stopping, the use of dermatoscopy will help dermatologists diagnose and treat it earlier and may therefore help lower the incidence of metastatic disease, according to Mark F. Naylor, M.D., in a presentation at the American Academy of Dermatology's Academy '05, here.
Patient/physician teamwork produces best rejuvenation outcomes
October 21st 2005Chicago — The trend toward non-invasive rejuvenation of the face is continually expanding with methods ranging from the simplest at-home therapies to aggressive, high-tech methods of removing as many signs of aging as possible.
Reloxin effects comparable to Botox
October 21st 2005Europe's version of Botox, Dysport (Ibsen-Biotech Laboratories) is poised to officially cross the Atlantic, mainly into the offices of U.S. cosmetic surgeons, once Food and Drug Administration (FDA) approval is obtained by its U.S. marketer, Santa Barbara, Calif.-based Inamed.
Botulinum toxin popularity surges; non-cosmetic applications emerging
October 21st 2005Chicago — The popularity of botulinum toxin type A injections for correcting wrinkles of the upper face has increased dramatically over the past few years. The extent of its popularity as a cosmetic procedure is obvious when this statistic is considered: The number of botulinum toxin type A procedures rose 157 percent from 2002 to 2003; the next highest increase was chemical peels, which rose a relatively sparse 48 percent over that same period.
Combining products benefits soft tissue augmentation
October 21st 2005In Dr. Baumann's experience, Sculptra is safe and effective for off-label cosmetic use alone or in combination with other fillers. The nature of the product makes it suitable not just for filling wrinkles, but for changing the structure of the face.
Targeting psoriatic plaques with a single, high dose of UVB yields favorable outcomes
October 21st 2005St. Louis — Turbo UVB phototherapy with the 308 nm excimer laser performed using a single high dose appears to be a well-tolerated and rapidly effective method for treating chronic plaque psoriasis, according to the results of an open-label pilot trial undertaken by dermatologists at Case Western Reserve University, Cleveland.
Anti-TNF-alpha agents OK in pregnancy
October 21st 2005National report — Preliminary review finds no adverse effects of anti-TNF-alpha agents on pregnancy outcomes. Analyses of limited data collected by the Organization of Teratology Information Services (OTIS) suggest there is no increased risk of major malformations or spontaneous abortions in women who received treatment with an anti-TNF-alpha medication early during pregnancy, reports Christina Chambers, Ph.D., M.P.H., who is current President of OTIS, assistant professor, departments of pediatrics and family and preventive medicine, University of California San Diego, La Jolla, Calif.
Arden, Allergan team-up to market 'new' Prevage
October 4th 2005New York - In what is believed to be the first product collaboration between a cosmetics company and a drug, Elizabeth Arden Inc. and Allergan Inc., the pharmaceutical firm that markets and distributes Botox, have teamed up to market a reformulated version of Allergan's anti-aging product, Prevage.